Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trialArshad M. Khanani, Francisco J. Rodríguez, Jordi Monés et al.|The Lancet|2023Cited by 343
Drusen volume development over time and its relevance to the course of age-related macular degenerationFerdinand Georg Schlanitz, Ursula Schmidt‐Erfurth, Bernhard Baumann et al.|British Journal of Ophthalmology|2016Cited by 156
Subretinal Drusenoid Deposits and Photoreceptor Loss Detecting Global and Local Progression of Geographic Atrophy by SD-OCT ImagingGregor S. Reiter, Ursula Schmidt‐Erfurth, Reinhard Told et al.|Investigative Ophthalmology & Visual Science|2020Cited by 70
Topographic Distribution and Progression of Soft Drusen Volume in Age-Related Macular Degeneration Implicate Neurobiology of FoveaAndreas Pollreisz, Ursula Schmidt‐Erfurth, Christine A. Curcio et al.|Investigative Ophthalmology & Visual Science|2021Cited by 60
INVESTIGATING A GROWTH PREDICTION MODEL IN ADVANCED AGE-RELATED MACULAR DEGENERATION WITH SOLITARY GEOGRAPHIC ATROPHY USING QUANTITATIVE AUTOFLUORESCENCEGregor S. Reiter, Andreas Pollreisz, Reinhard Told et al.|Retina|2019Cited by 24